Samsrita Labs (BOM:539267) Debt-to-Asset : 0.00 (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Samsrita Labs Debt-to-Asset?

Samsrita Labs's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0.00 Mil. Samsrita Labs's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0.00 Mil. Samsrita Labs's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ₹0.00 Mil.

Samsrita Labs Debt-to-Asset Historical Data

The historical data trend for Samsrita Labs's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsrita Labs Debt-to-Asset Chart

Samsrita Labs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

Get a 7-Day Free Trial

0.30

0.14

0.16

0.13

0.14

Samsrita Labs Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial															-	0.14	-	0.15	-

Competitive Comparison of Samsrita Labs's Debt-to-Asset

For the Diagnostics & Research subindustry, Samsrita Labs's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Samsrita Labs's Debt-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Samsrita Labs's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Samsrita Labs's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Samsrita Labs Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Samsrita Labs's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(22.032	+	0)	/	155.514
	=	0.14

Samsrita Labs's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	0
	=	N/A

Samsrita Labs (BOM:539267) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Samsrita Labs Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Samsrita Labs's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Samsrita Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Samsrita Labs Ltd (BOM:539267) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Suryateja Apartments, 6-3-354/13/B2, Flat No. B2, Hindinagar, Punjagutta, Hyderabad, TG, IND, 500082

Website

https://www.drhlsl.com

Samsrita Labs Ltd is an India based diversified healthcare company. The company's operations include research and excellence in the areas of Stem cell research and development and therapy, New drug discovery, Diagnostics and Bio Lab, Pharmacy, Out-Patient Consultancy Division in name of ORIGIN HOSPITALS, and Research and Development in Biotechnology. It has one reportable segment namely, healthcare services including hospital, diagnostics, Pharma, and Biotechnology.

Samsrita Labs Headlines

No Headlines